SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-18-000292
Filing Date
2018-09-26
Accepted
2018-09-26 09:44:46
Documents
59
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K zander063018form10k.htm 10-K 994231
2 EXHIBIT 10.13 ex10_13.htm EX-10.13 59752
3 EXHIBIT 10.14 ex10_14.htm EX-10.14 54845
4 EXHIBIT 10.21 ex10_21.htm EX-10.21 117660
5 EXHIBIT 10.22 ex10_22.htm EX-10.22 29264
6 EXHIBIT 10.23 ex10_23.htm EX-10.23 41348
7 EXHIBIT 10.24 ex10_24.htm EX-10.24 63164
8 EXHIBIT 10.25 ex10_25.htm EX-10.25 21910
9 EXHIBIT 10.26 ex10_26.htm EX-10.26 24018
10 EXHIBIT 31.1 ex31_1.htm EX-31.1 7348
11 EXHIBIT 31.2 ex31_2.htm EX-31.2 7433
12 EXHIBIT 32.1 ex32_1.htm EX-32.1 4208
13 EXHIBIT 32.2 ex32_2.htm EX-32.2 4377
  Complete submission text file 0001607062-18-000292.txt   3858986

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE zander-20180630.xml EX-101.INS 499434
15 XBRL SCHEMA FILE zander-20180630.xsd EX-101.SCH 39611
16 XBRL CALCULATION FILE zander-20180630_cal.xml EX-101.CAL 30810
17 XBRL DEFINITION FILE zander-20180630_def.xml EX-101.DEF 186030
18 XBRL LABEL FILE zander-20180630_lab.xml EX-101.LAB 155697
19 XBRL PRESENTATION FILE zander-20180630_pre.xml EX-101.PRE 206200
Mailing Address 4700 SPRING ST LA MESA CA 91942-0274
Business Address 4700 SPRING ST LA MESA CA 91942-0274 6192279192
Zander Therapeutics, Inc (Filer) CIK: 0001718644 (see all company filings)

IRS No.: 474321638 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 333-220790 | Film No.: 181086977
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1